Asia Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022
Report Highlights
The Asia Pacific lateral flow immunoassay (LFIA) based rapid test market grew from $1547.8 million in 2016 to $2,924.5 million in 2021 at a compound annual growth rate (CAGR) of 13.6%. The Asia Pacific lateral flow immunoassay (LFIA) based rapid test market is expected to decline from $2924.5 million in 2021 to $1666.6 million in 2026 at a compound annual growth rate (CAGR) of -10.6%.
Asia Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022 provides strategists, marketers and senior management with the critical information they need to assess the Asia Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test market.
Reasons to Purchase
- Fully updated for 2022.
- Identify growth segments and opportunities.
- Facilitate decision making on the basis of historic and forecast data
- Develop strategies based on likely future developments.
- Gain a global perspective on the development of the market.
Description
Asia Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2022 from the Business Research Company covers market characteristics, size and growth, trends and strategies for this market.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the Lateral Flow Immunoassay (LFIA) Based Rapid Test market revenues, covering both the historic growth of the market and forecasting the future.
- The trends and strategies section highlights the likely future developments in the Lateral Flow Immunoassay (LFIA) Based Rapid Test market and suggests approaches.
Scope
Markets Covered: Lateral Flow Immunoassay (LFIA) Based Rapid Test
Geographic scope: Asia Pacific
Time series: Five years historic and forecast
Data: Market value in $ billions.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
- Table 1 : Asia Pacific GDP Per Capita, 2015-2020, $
- Table 2 : Asia-Pacific, Population By Age Group, By Country, 2015-2025, Thousands
- Table 3 : Asia-Pacific Public Healthcare Expenditure, 2015-2020, $ Billion
- Table 4 : Asia-Pacific Private Healthcare Expenditure, 2015-2020, $ Billion
- Table 5 : Asia-Pacific Healthcare Services Market Size, 2016-2026, $ Billion
- Table 6 : Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
- Table 7 : Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
- Table 8 : Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
- Table 9 : Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, $ Million
- Table 10 : Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Data Sources
- Figure 1 : Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Historic, 2016 – 2021, $ Million
- Figure 2 : Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Forecast, 2021 – 2026, 2031F, $ Million
- Figure 3 : Asia-Pacific Lateral Flow Immunoassay (LFIA) Based Rapid Test Market, Segmentation By Application, Historic And Forecast, 2016 – 2021, 2026F, 2031F, %
The Business Research Company is a market research and intelligence company which excels in company, market and consumer research. It has over 50 research professionals at its offices in India, the UK and the US as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.